☰

Mary Sano, PhD, City University of New York Graduate Center - Publications

Affiliations: 
Psychiatry Icahn School of Medicine at Mount Sinai, New York, NY, United States 
Area:
http://www.researchprofiles.collexis.com/jad/expert.asp?u_id=84
Website:
http://www.mountsinai.org/profiles/mary-sano
Tree Info Grants Similar researchers PubMed Report error

286 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Grossman HT, Sano M, Aloysi A, Elder GA, Neugroschl J, Schimming C, Soleimani L, Zhu CW. Prevalent, persistent, and impairing: Longitudinal course and impact of apathy in Alzheimer's disease. Alzheimer's & Dementia (Amsterdam, Netherlands). 13: e12169. PMID 35141391 DOI: 10.1002/dad2.12169  0.313
2021 Zhu CW, Sano M. Demographic, Health, and Exposure Risks Associated With Cognitive Loss, Alzheimer's Disease and Other Dementias in US Military Veterans. Frontiers in Psychiatry. 12: 610334. PMID 33716816 DOI: 10.3389/fpsyt.2021.610334  0.307
2020 Ganmore I, Elkayam I, Ravona-Springer R, Lin HM, Liu X, Plotnik M, Buchman AS, Berman Y, Schwartz J, Sano M, Heymann A, Beeri MS. Deterioration in Motor Function Over Time in Older Adults With Type 2 Diabetes is Associated with Accelerated Cognitive Decline. Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 26: 1143-1152. PMID 33471716 DOI: 10.4158/Ep-2020-0289  0.343
2020 Nir T, Jacob Y, Huang KH, Schwartz AE, Brallier JW, Ahn H, Kundu P, Tang CY, Delman BN, McCormick PJ, Sano M, Deiner S, Baxter MG, Mincer JS. Resting-state functional connectivity in early postanaesthesia recovery is characterised by globally reduced anticorrelations. British Journal of Anaesthesia. PMID 32800503 DOI: 10.1016/J.Bja.2020.06.058  0.332
2020 Clouston SAP, Deri Y, Horton M, Tang C, Diminich E, DeLorenzo C, Kritikos M, Pellecchia AC, Santiago-Michels S, Carr MA, Gandy S, Sano M, Bromet EJ, Lucchini RG, Luft BJ. Reduced cortical thickness in World Trade Center responders with cognitive impairment. Alzheimer's & Dementia (Amsterdam, Netherlands). 12: e12059. PMID 32695871 DOI: 10.1002/Dad2.12059  0.35
2020 Cao J, Huang M, Guo L, Zhu L, Hou J, Zhang L, Pero A, Ng S, El Gaamouch F, Elder G, Sano M, Goate A, Tcw J, Haroutunian V, Zhang B, et al. MicroRNA-195 rescues ApoE4-induced cognitive deficits and lysosomal defects in Alzheimer's disease pathogenesis. Molecular Psychiatry. PMID 32632205 DOI: 10.1038/S41380-020-0824-3  0.335
2020 Sano M, Zhu CW. Response to Schneider and Goldberg "Composite cognitive and functional measures for early stage Alzheimer's disease trials". Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring. 12. PMID 32432154 DOI: 10.1002/Dad2.12015  0.414
2020 Knopman D, Lemere CA, Lamb BT, Craft S, Gitlin LN, Golde TE, Pericak-Vance M, Sano M, Schellenberg G, Schneider JA, Zheng H, Khachaturian Z, Snyder HM, Carrillo MC. Scientific Advising and Reviewing: On strengthening the bond between the Alzheimer's Association and the scientific community. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 32426924 DOI: 10.1002/Alz.12059  0.338
2020 Kritikos M, Clouston SAP, Diminich ED, Deri Y, Yang X, Carr M, Gandy S, Sano M, Bromet EJ, Luft BJ. Pathway Analysis for Plasma β-Amyloid, Tau and Neurofilament Light (ATN) in World Trade Center Responders at Midlife. Neurology and Therapy. PMID 32350803 DOI: 10.1007/S40120-020-00189-1  0.359
2020 BenAri O, Efrati S, Sano M, Bendlin BB, Lin H, Liu X, Sela I, Almog G, Livny A, Sandler I, Ben-Haim S, Sagi R, LeRoith D, Schnaider Beeri M, Ravona-Springer R. A double-blind placebo-controlled clinical trial testing the effect of hyperbaric oxygen therapy on brain and cognitive outcomes of mildly cognitively impaired elderly with type 2 diabetes: Study design. Alzheimer's & Dementia (New York, N. Y.). 6: e12008. PMID 32296731 DOI: 10.1002/Trc2.12008  0.365
2020 Van Rickstal R, De Vleminck A, Morrison SR, Koopmans RT, van der Steen JT, Engelborghs S, Neugroschl J, Aldridge MD, Sano M, Van den Block L. Comparing Advance Care Planning in Young-Onset Dementia in the USA vs Belgium: Challenges Partly Related to Societal Context. Journal of the American Medical Directors Association. PMID 32173310 DOI: 10.1016/J.Jamda.2020.01.007  0.308
2020 Galik E, Sano M, Lapid MI, Reichman WE. International Psychogeriatric Association (Ipa): Topics In Aging And Mental Health American Journal of Geriatric Psychiatry. 28. DOI: 10.1016/J.Jagp.2020.01.036  0.314
2019 Silverman JM, Schmeidler J, Lee PG, Alexander NB, Beeri MS, Guerrero-Berroa E, West RK, Sano M, Nabozny M, Rodriguez Alvarez C. Associations of hemoglobin A1c with cognition reduced for long diabetes duration. Alzheimer's & Dementia (New York, N. Y.). 5: 926-932. PMID 31890856 DOI: 10.1016/J.Trci.2019.11.009  0.337
2019 Fischer CE, Ismail Z, Youakim JM, Creese B, Kumar S, Nuñez N, Darby RR, Di Vita A, D'Antonio F, de Lena C, McGeown WJ, Ramit R, Rasmussen J, Bell J, Wang H, ... ... Sano M, et al. Revisiting Criteria for Psychosis in Alzheimer's Disease and Related Dementias: Toward Better Phenotypic Classification and Biomarker Research. Journal of Alzheimer's Disease : Jad. PMID 31884469 DOI: 10.3233/Jad-190828  0.406
2019 Clouston SAP, Diminich ED, Kotov R, Pietrzak RH, Richards M, Spiro A, Deri Y, Carr M, Yang X, Gandy S, Sano M, Bromet EJ, Luft BJ. Incidence of mild cognitive impairment in World Trade Center responders: Long-term consequences of re-experiencing the events on 9/11/2001. Alzheimer's & Dementia (Amsterdam, Netherlands). 11: 628-636. PMID 31517025 DOI: 10.1016/J.Dadm.2019.07.006  0.356
2019 Karran M, Guerrero-Berroa E, Schmeidler J, Lee PG, Alexander N, Nabozny M, West RK, Beeri MS, Sano M, Silverman JM. Recruitment of Older Veterans with Diabetes Risk for Alzheimer's Disease for a Randomized Clinical Trial of Computerized Cognitive Training. Journal of Alzheimer's Disease : Jad. PMID 31006684 DOI: 10.3233/Jad-180952  0.423
2019 Deiner S, Liu X, Lin HM, Sieber F, Boockvar K, Sano M, Baxter MG. Subjective cognitive complaints in patients undergoing major non-cardiac surgery: a prosepective single centre cohort trial. British Journal of Anaesthesia. PMID 31003631 DOI: 10.1016/J.Bja.2019.02.027  0.373
2019 West RK, Rabin LA, Silverman JM, Moshier E, Sano M, Beeri MS. Short-term computerized cognitive training does not improve cognition compared to an active control in non-demented adults aged 80 years and above. International Psychogeriatrics. 1-9. PMID 30968798 DOI: 10.1017/S1041610219000267  0.373
2019 Sano M, Zhu CW, Kaye J, Mundt JC, Hayes TL, Ferris S, Thomas RG, Sun CK, Jiang Y, Donohue MC, Schneider LS, Egelko S, Aisen PS, Feldman HH. A randomized clinical trial to evaluate home-based assessment of people over 75 years old. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 30872114 DOI: 10.1016/J.Jalz.2019.01.007  0.331
2019 Zhu CW, Grossman HT, Sano M. Why Do They Just Sit? Apathy as a Core Symptom of Alzheimer Disease American Journal of Geriatric Psychiatry. 27: 395-405. PMID 30655032 DOI: 10.1016/J.Jagp.2018.12.013  0.382
2019 Pun K, Zhu CW, Kinsella MT, Li C, Grossman H, Neugroschl J, Sewell M, Velasco N, Bayus J, Sano M. P1‐547: Mailing Outreach For Participation In Cognitive Impairment And Alzheimer'S Disease Research Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.1152  0.443
2019 Li C, Neugroschl J, Zhu CW, Umpierre M, Martin J, Zeng X, Huang Q, Grossman H, Cai D, Sewell M, Sano M. P1-471: The Utility Of Verbal Memory Tests As Sensitive Markers For Early-Stage Alzheimer'S Disease In Elderly Chinese Americans Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.1076  0.335
2018 Soleimani L, Ravona-Springer R, Heymann A, Guerrero-Berroa E, Schmeidler J, Zukran R, Preiss R, Silverman JM, Sano M, Beeri MS. Depression is more strongly associated with cognition in elderly women than men with type 2 diabetes. International Psychogeriatrics. 1-5. PMID 30526693 DOI: 10.1017/S104161021800114X  0.342
2018 Zhu CW, Grossman H, Neugroschl J, Parker S, Burden A, Luo X, Sano M. A randomized, double-blind, placebo-controlled trial of resveratrol with glucose and malate (RGM) to slow the progression of Alzheimer's disease: A pilot study. Alzheimer's & Dementia (New York, N. Y.). 4: 609-616. PMID 30480082 DOI: 10.1016/J.Trci.2018.09.009  0.363
2018 Sano M, Egelko S, Zhu CW, Li C, Donohue MC, Ferris S, Kaye J, Mundt JC, Sun CK, Aisen PS, Feldman HH. Participant satisfaction with dementia prevention research: Results from Home-Based Assessment trial. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 30297140 DOI: 10.1016/J.Jalz.2018.05.016  0.351
2018 Li C, Neugroschl J, Zhu CW, Umpierre M, Martin J, Zeng X, Huang Q, Grossman H, Cai D, Sano M. Cognitive test battery for evaluating elderly Chinese Americans. International Psychogeriatrics. 1-7. PMID 30277186 DOI: 10.1017/S1041610218001060  0.34
2018 Belitskaya-Lévy I, Dysken M, Guarino P, Sano M, Asthana S, Vertrees JE, Pallaki M, Llorente M, Love S, Schellenberg G. Impact of apolipoprotein E genotypes on vitamin E and memantine treatment outcomes in Alzheimer's disease. Alzheimer's & Dementia (New York, N. Y.). 4: 344-349. PMID 30175228 DOI: 10.1016/J.Trci.2018.06.001  0.366
2018 Guerrero-Berroa E, Ravona-Springer R, Schmeidler J, Heymann A, Soleimani L, Sano M, Leroith D, Preiss R, Zukran R, Silverman JM, Beeri MS. Depressive Symptoms are Associated with Cognitive Function in Elderly with Type 2 Diabetes. Journal of Alzheimer's Disease : Jad. PMID 30103313 DOI: 10.3233/Jad-170778  0.379
2018 Barcelos NM, Van Ness PH, Wagner AF, MacAvoy MG, Mecca AP, Anderson GM, Trentalange M, Hawkins KA, Sano M, Arnsten AFT, van Dyck CH. Guanfacine treatment for prefrontal cognitive dysfunction in older participants: a randomized clinical trial. Neurobiology of Aging. 70: 117-124. PMID 30007160 DOI: 10.1016/J.Neurobiolaging.2018.05.033  0.359
2018 Chen P, Guarino PD, Dysken MW, Pallaki M, Asthana S, Llorente MD, Love S, Vertrees JE, Schellenberg GD, Sano M. Neuropsychiatric Symptoms and Caregiver Burden in Individuals With Alzheimer's Disease: The TEAM-AD VA Cooperative Study. Journal of Geriatric Psychiatry and Neurology. 891988718783897. PMID 29966477 DOI: 10.1177/0891988718783897  0.382
2018 Readhead B, Haure-Mirande JV, Funk CC, Richards MA, Shannon P, Haroutunian V, Sano M, Liang WS, Beckmann ND, Price ND, Reiman EM, Schadt EE, Ehrlich ME, Gandy S, Dudley JT. Multiscale Analysis of Independent Alzheimer's Cohorts Finds Disruption of Molecular, Genetic, and Clinical Networks by Human Herpesvirus. Neuron. PMID 29937276 DOI: 10.1016/J.Neuron.2018.05.023  0.338
2018 Knopman DS, Haeberlein SB, Carrillo MC, Hendrix JA, Kerchner G, Margolin R, Maruff P, Miller DS, Tong G, Tome MB, Murray ME, Nelson PT, Sano M, Mattsson N, Sultzer DL, et al. The National Institute on Aging and the Alzheimer's Association Research Framework for Alzheimer's disease: Perspectives from the Research Roundtable. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 14: 563-575. PMID 29653607 DOI: 10.1016/J.Jalz.2018.03.002  0.354
2018 Becker RE, Greig NH, Lahiri DK, Bledsoe J, Majercik S, Ballard C, Aarsland D, Schneiderh LS, Flanagan D, Govindarajani R, Sano M, Ferrucci L, Kapogiannisk D. (-)-Phenserine and Inhibiting Pre-Programmed Cell Death: In Pursuit of a Novel Intervention for Alzheimer's Disease. Current Alzheimer Research. PMID 29318971 DOI: 10.2174/1567205015666180110120026  0.391
2018 Atri A, Knopman DS, Norman M, Karlawish J, Sano M, Onyike CU, Lin P, Clevenger C, Scanland S, Hendrix J, Carrillo MC, Dickerson BC. P4-288: Details Of The New Alzheimer'S Association Best Clinical Practice Guidelines For The Evaluation Of Neurodegenerative Cognitive Behavioral Syndromes, Alzheimer'S Disease And Dementias In The United States Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.07.110  0.433
2018 Beeri MS, Lin H, Ravona-Springer R, Sano M, Bendlin BB, Gleason CE, Guerrero-Berroa E, Soleimani L, Launer LJ, Levy A. O1-14-02: The Haptoglobin 1-1 Genotype Is Associated With Cognitive Function And Decline In African American Persons With Type 2 Diabetes: The Accord-Mind Study Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.3048  0.317
2018 Burnham SC, Coloma PM, Dartigues J, Doody R, Hansson O, Helmer C, Kass JS, Masters CL, Palmqvist S, Pavlik VN, Petersen RC, Roberts RO, Schaeuble B, Sano M. P4-078: Concorde-Ad: An International Network Of Cohorts For Better Understanding Of Alzheimer'S Disease Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2481  0.371
2018 Guerrero-Berroa E, Schmeidler J, Haroutunian V, Arneson J, West R, Beeri MS, Sano M, Silverman JM. P2-607: Depressive Symptoms Predict Cognitive Decline In Older Adults Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.1303  0.307
2018 Shuvayev I, Zhu C, Schimming C, Sano M. Comparison of Cognitive Status, Psychopathology, and Functional Performance of Minority Older Adults with and Without Type 2 Diabetes American Journal of Geriatric Psychiatry. 26. DOI: 10.1016/J.Jagp.2018.01.141  0.309
2017 Mincer JS, Baxter MG, McCormick PJ, Sano M, Schwartz AE, Brallier JW, Allore HG, Delman BN, Sewell MC, Kundu P, Tang CY, Sanchez A, Deiner SG. Delineating the Trajectory of Cognitive Recovery From General Anesthesia in Older Adults: Design and Rationale of the TORIE (Trajectory of Recovery in the Elderly) Project. Anesthesia and Analgesia. PMID 28891911 DOI: 10.1213/Ane.0000000000002427  0.356
2017 Livny A, Ravona-Springer R, Heymann A, Priess R, Kushnir T, Tsarfaty G, Rabinov L, Moran R, Tik N, Moshier E, Cooper I, Greenbaum L, Silverman J, Levy A, Sano M, et al. The Haptoglobin 1-1 Genotype Modulates the Association of Glycemic Control with Hippocampal Volume in Elderly with Type 2 Diabetes. Diabetes. PMID 28860127 DOI: 10.2337/Db16-0987  0.314
2017 Li C, Neugroschl J, Luo X, Zhu C, Aisen P, Ferris S, Sano M. The Utility of the Cognitive Function Instrument (CFI) to Detect Cognitive Decline in Non-Demented Older Adults. Journal of Alzheimer's Disease : Jad. PMID 28854503 DOI: 10.3233/Jad-161294  0.366
2017 Sano M, Zhu CW, Grossman H, Schimming C. Longitudinal Cognitive Profiles in Diabetes: Results From the National Alzheimer's Coordinating Center's Uniform Data. Journal of the American Geriatrics Society. PMID 28771679 DOI: 10.1111/Jgs.15014  0.423
2017 Sims R, van der Lee SJ, Naj AC, Bellenguez C, Badarinarayan N, Jakobsdottir J, Kunkle BW, Boland A, Raybould R, Bis JC, Martin ER, Grenier-Boley B, Heilmann-Heimbach S, Chouraki V, Kuzma AB, ... ... Sano M, et al. Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease. Nature Genetics. PMID 28714976 DOI: 10.1038/Ng.3916  0.323
2017 Gandy S, Bartfai T, Lees GV, Sano M. Midlife interventions are critical in prevention, delay, or improvement of Alzheimer's disease and vascular cognitive impairment and dementia. F1000research. 6: 413. PMID 28491285 DOI: 10.12688/F1000Research.11140.1  0.415
2017 Relkin NR, Thomas RG, Rissman RA, Brewer JB, Rafii MS, van Dyck CH, Jack CR, Sano M, Knopman DS, Raman R, Szabo P, Gelmont DM, Fritsch S, Aisen PS. A phase 3 trial of IV immunoglobulin for Alzheimer disease. Neurology. PMID 28381506 DOI: 10.1212/Wnl.0000000000003904  0.414
2017 Lee P, Guerrero-Berroa E, Schmeidler J, Schnaider-Beeri M, West R, Sano M, Alexander N, Silverman JM. Older Veterans With Type 2 Diabetes: A1C And Cognitive Function Innovation in Aging. 1: 470-470. DOI: 10.1093/Geroni/Igx004.1674  0.32
2017 Zhu CW, Grossman H, Schimming C, Sano M. Non-Amnestic Deficit Characterizes The Cognitive Profile In Diabetes: Results From National Alzheimer'S Coordinating Center'S Uniform Data Set (Nacc Uds) Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.06.518  0.378
2016 Guarino PD, Vertrees JE, Asthana S, Sano M, Llorente MD, Pallaki M, Love S, Schellenberg GD, Dysken MW. Measuring informed consent capacity in an Alzheimer's disease clinical trial. Alzheimer's & Dementia (New York, N. Y.). 2: 258-266. PMID 29067313 DOI: 10.1016/J.Trci.2016.09.001  0.408
2016 Hager K, Baseman AS, Nye JS, Brashear HR, Han J, Sano M, Davis B, Richards HM. Effect of concomitant use of memantine on mortality and efficacy outcomes of galantamine-treated patients with Alzheimer's disease: post-hoc analysis of a randomized placebo-controlled study. Alzheimer's Research & Therapy. 8: 47. PMID 27846868 DOI: 10.1186/s13195-016-0214-x  0.311
2016 Li C, Neugroschl J, Umpierre M, Martin J, Huang Q, Zeng X, Cai D, Sano M. Recruiting US Chinese Elders Into Clinical Research for Dementia. Alzheimer Disease and Associated Disorders. PMID 27819841 DOI: 10.1097/Wad.0000000000000162  0.356
2016 Sano M, Aisen PS, Andrews HF, Tsai WY, Lai F, Dalton AJ. Vitamin E in aging persons with Down syndrome: A randomized, placebo-controlled clinical trial. Neurology. PMID 27164691 DOI: 10.1212/Wnl.0000000000002714  0.337
2016 West RK, Ravona-Springer R, Heymann A, Schmeidler J, Leroith D, Koifman K, D'Arcy RC, Song X, Guerrero-Berroa E, Preiss R, Hoffman H, Sano M, Silverman JM, Schnaider-Beeri M. Waist circumference is correlated with poorer cognition in elderly type 2 diabetes women. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 27149905 DOI: 10.1016/J.Jalz.2016.03.017  0.359
2016 Neugroschl J, Sewell M, De La Fuente A, Umpierre M, Luo X, Sano M. Attitudes and Perceptions of Research in Aging and Dementia in an Urban Minority Population. Journal of Alzheimer's Disease : Jad. PMID 27128368 DOI: 10.3233/Jad-151072  0.331
2016 Sano M, Gandy S. Sex differences in cognition Does the “fairer sex” need a fairer test? Neurology. 86: 1364-1365. PMID 26984948 DOI: 10.1212/Wnl.0000000000002573  0.433
2016 Guerrero-Berroa E, Schmeidler J, Raventos H, Valerio D, Beeri MS, Carrión-Baralt JR, Mora-Villalobos L, Bolaños P, Sano M, Silverman JM. Neuropsychological Test Performance in Cognitively Normal Spanish-speaking Nonagenarians with Little Education. Journal of Cross-Cultural Gerontology. PMID 26883764 DOI: 10.1007/S10823-016-9285-1  0.321
2016 Zhu CW, Luo X, Schimming C, Grossman H, Sano M. P4-360: Longitudinal Effects of Diabetes on Cognitive Decline: Results From the National Alzheimer's Coordinating Center's Uniform Data Set (NACC UDS) Alzheimer's & Dementia. 12: P1175-P1175. DOI: 10.1016/J.Jalz.2016.07.105  0.385
2016 Guerrero-Berroa E, Ravona-Springer R, Schmeidler J, Heymann A, Soleimani L, Sano M, Leroith D, Preiss R, Hoffman H, Silverman JM, Beeri MS. Neuropsychiatric Symptoms Are Associated With Cognitive Function In Elderly With Type 2 Diabetes Alzheimers & Dementia. 12: 993. DOI: 10.1016/J.Jalz.2016.06.2041  0.329
2016 Sano M, Sewell M, Umpierre M, Neugroschl J, Cedillo G. Barriers To Cognitive Evaluations Among Elderly Latinos: Using Community-Based Participatory Research To Create Health Education Videos Alzheimers & Dementia. 12. DOI: 10.1016/J.Jalz.2016.06.1594  0.307
2016 Li C, Neugroschl J, Umpierre M, Martin J, Huang Q, Zeng X, Cai D, Sano M. Beijing Version Of The Montreal Cognitive Assessment For Elderly Chinese Americans Alzheimers & Dementia. 12: 567. DOI: 10.1016/J.Jalz.2016.06.1109  0.356
2015 Greenbaum L, Ravona-Springer R, Lubitz I, Schmeidler J, Cooper I, Sano M, Silverman JM, Heymann A, Beeri MS. Potential contribution of the Alzheimer׳s disease risk locus BIN1 to episodic memory performance in cognitively normal Type 2 diabetes elderly. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 26947052 DOI: 10.1016/J.Euroneuro.2015.11.004  0.411
2015 Deiner S, Luo X, Silverstein JH, Sano M. Can Intraoperative Processed EEG Predict Postoperative Cognitive Dysfunction in the Elderly? Clinical Therapeutics. PMID 26621628 DOI: 10.1016/J.Clinthera.2015.11.004  0.353
2015 Gandy S, Sano M. Alzheimer disease: Solanezumab-prospects for meaningful interventions in AD? Nature Reviews. Neurology. 11: 669-70. PMID 26526537 DOI: 10.1038/Nrneurol.2015.218  0.4
2015 Guerrero-Berroa E, Ravona-Springer R, Heymann A, Schmeidler J, Hoffman H, Preiss R, Koifmann K, Greenbaum L, Levy A, Silverman JM, Leroith D, Sano M, Schnaider-Beeri M. Ethnicity/culture modulates the relationships of the haptoglobin (Hp) 1-1 phenotype with cognitive function in older individuals with type 2 diabetes. International Journal of Geriatric Psychiatry. PMID 26388309 DOI: 10.1002/Gps.4354  0.391
2015 Zhu L, Zhong M, Elder GA, Sano M, Holtzman DM, Gandy S, Cardozo C, Haroutunian V, Robakis NK, Cai D. Phospholipid dysregulation contributes to ApoE4-associated cognitive deficits in Alzheimer's disease pathogenesis. Proceedings of the National Academy of Sciences of the United States of America. 112: 11965-70. PMID 26372964 DOI: 10.1073/Pnas.1510011112  0.382
2015 Ray M, Sano M, Wisnivesky JP, Wolf MS, Federman AD. Asthma control and cognitive function in a cohort of elderly adults. Journal of the American Geriatrics Society. 63: 684-91. PMID 25854286 DOI: 10.1111/Jgs.13350  0.344
2015 Wang LS, Naj AC, Graham RR, Crane PK, Kunkle BW, Cruchaga C, Murcia JD, Cannon-Albright L, Baldwin CT, Zetterberg H, Blennow K, Kukull WA, Faber KM, Schupf N, Norton MC, ... ... Sano M, et al. Rarity of the Alzheimer disease-protective APP A673T variant in the United States. Jama Neurology. 72: 209-16. PMID 25531812 DOI: 10.1001/Jamaneurol.2014.2157  0.384
2015 Cummings J, Mintzer J, Brodaty H, Sano M, Banerjee S, Devanand DP, Gauthier S, Howard R, Lanctôt K, Lyketsos CG, Peskind E, Porsteinsson AP, Reich E, Sampaio C, Steffens D, et al. Agitation in cognitive disorders: International Psychogeriatric Association provisional consensus clinical and research definition. International Psychogeriatrics / Ipa. 27: 7-17. PMID 25311499 DOI: 10.1017/S1041610214001963  0.338
2015 O'Conor R, Wolf MS, Smith SG, Martynenko M, Vicencio DP, Sano M, Wisnivesky JP, Federman AD. Health literacy, cognitive function, proper use, and adherence to inhaled asthma controller medications among older adults with asthma. Chest. 147: 1307-15. PMID 25275432 DOI: 10.1378/Chest.14-0914  0.318
2015 Hise CV, Akinleye L, Grossman H, Elder G, Cai D, Gandy S, Luo X, Sano M. The challenges of recruiting individuals with mild cognitive impairment (MCI) for biomarker studies in a veteran population Alzheimers & Dementia. 11. DOI: 10.1016/J.Jalz.2015.06.990  0.376
2015 Beeri M, Ravona-Springer R, Heymann A, Schmeidler J, Hoffman H, Preiss R, Koifman K, Levy A, Silverman JM, Leroith D, Sano M. Ethnicity/culture modulates the relationships of the haptoblobin (Hp) 1-1 phenotype with cognitive function in elderly with type 2 diabetes Alzheimers & Dementia. 11: 727. DOI: 10.1016/J.Jalz.2015.06.1624  0.311
2014 Neugroschl J, Sano M, Luo X, Sewell M. Why They Stay: Understanding Research Participant Retention in Studies of Aging, Cognitive Impairment and Dementia. Journal of Gerontology & Geriatric Research. 3. PMID 25520902 DOI: 10.4172/2167-7182.1000170  0.335
2014 Fargo KN, Aisen P, Albert M, Au R, Corrada MM, DeKosky S, Drachman D, Fillit H, Gitlin L, Haas M, Herrup K, Kawas C, Khachaturian AS, Khachaturian ZS, ... ... Sano M, et al. 2014 Report on the Milestones for the US National Plan to Address Alzheimer's Disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 10: S430-52. PMID 25341459 DOI: 10.1016/J.Jalz.2014.08.103  0.365
2014 Donohue MC, Moghadam SH, Roe AD, Sun CK, Edland SD, Thomas RG, Petersen RC, Sano M, Galasko D, Aisen PS, Rissman RA. Longitudinal plasma amyloid beta in Alzheimer's disease clinical trials. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 25301682 DOI: 10.1016/J.Jalz.2014.07.156  0.363
2014 Mitsis EM, Riggio S, Kostakoglu L, Dickstein DL, Machac J, Delman B, Goldstein M, Jennings D, D'Antonio E, Martin J, Naidich TP, Aloysi A, Fernandez C, Seibyl J, DeKosky ST, ... ... Sano M, et al. Tauopathy PET and amyloid PET in the diagnosis of chronic traumatic encephalopathies: studies of a retired NFL player and of a man with FTD and a severe head injury. Translational Psychiatry. 4: e441. PMID 25226550 DOI: 10.1038/Tp.2014.91  0.305
2014 Naj AC, Jun G, Reitz C, Kunkle BW, Perry W, Park YS, Beecham GW, Rajbhandary RA, Hamilton-Nelson KL, Wang LS, Kauwe JS, Huentelman MJ, Myers AJ, Bird TD, Boeve BF, ... ... Sano M, et al. Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study. Jama Neurology. 71: 1394-404. PMID 25199842 DOI: 10.1001/Jamaneurol.2014.1491  0.328
2014 Greenbaum L, Springer RR, Lutz MW, Heymann A, Lubitz I, Cooper I, Kravitz E, Sano M, Roses AD, Silverman JM, Saunders AM, Beeri MS. The TOMM40 poly-T rs10524523 variant is associated with cognitive performance among non-demented elderly with type 2 diabetes. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 24: 1492-9. PMID 25044051 DOI: 10.1016/J.Euroneuro.2014.06.002  0.402
2014 Guerrero-Berroa E, Ravona-Springer R, Heymann A, Schmeidler J, Silverman JM, Sano M, Koifmann K, Preiss R, Hoffman H, Schnaider Beeri M. Decreased motor function is associated with poorer cognitive function in elderly with type 2 diabetes. Dementia and Geriatric Cognitive Disorders Extra. 4: 103-12. PMID 24926308 DOI: 10.1159/000360280  0.36
2014 Ravona-Springer R, Heymann A, Schmeidler J, Moshier E, Godbold J, Sano M, Leroith D, Johnson S, Preiss R, Koifman K, Hoffman H, Silverman JM, Beeri MS. Trajectories in glycemic control over time are associated with cognitive performance in elderly subjects with type 2 diabetes. Plos One. 9: e97384. PMID 24887092 DOI: 10.1371/Journal.Pone.0097384  0.383
2014 Ravona-Springer R, Heymann A, Schmeidler J, Sano M, Preiss R, Koifman K, Hoffman H, Silverman JM, Beeri MS. The ApoE4 genotype modifies the relationship of long-term glycemic control with cognitive functioning in elderly with type 2 diabetes. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 24: 1303-8. PMID 24875283 DOI: 10.1016/J.Euroneuro.2014.05.001  0.324
2014 Zhu CW, Sano M, Ferris SH, Whitehouse PJ, Patterson MB, Galasko D, Schneider LS, Aisen PS. Alzheimer's Disease Cooperative Study Prevention Instrument Project assessing resource use and volunteer and paid work in healthy elders: a longitudinal study. Journal of the American Geriatrics Society. 62: 985-8. PMID 24828933 DOI: 10.1111/Jgs.12816  0.359
2014 Post JB, Morin KG, Handrakis JP, Rivera DR, Yen C, Sano M, Spungen AM. Cognition may be related to arterial pulsatility index in HD patients. Clinical Nephrology. 81: 313-9. PMID 24780553 DOI: 10.5414/Cn107998  0.394
2014 Hager K, Baseman AS, Nye JS, Brashear HR, Han J, Sano M, Davis B, Richards HM. Effects of galantamine in a 2-year, randomized, placebo-controlled study in Alzheimer's disease. Neuropsychiatric Disease and Treatment. 10: 391-401. PMID 24591834 DOI: 10.2147/NDT.S57909  0.318
2014 Dal Pan G, Stern Y, Sano M, Mayeux R. Clock-drawing in neurological disorders. Behavioural Neurology. 2: 39-48. PMID 24486944 DOI: 10.3233/Ben-1989-2104  0.396
2014 Mitsis EM, Bender HA, Kostakoglu L, Machac J, Martin J, Woehr JL, Sewell MC, Aloysi A, Goldstein MA, Li C, Sano M, Gandy S. A consecutive case series experience with [18 F] florbetapir PET imaging in an urban dementia center: impact on quality of life, decision making, and disposition. Molecular Neurodegeneration. 9: 10. PMID 24484858 DOI: 10.1186/1750-1326-9-10  0.335
2014 Benson G, de Felipe J, Xiaodong, Sano M. Performance of Spanish-speaking community-dwelling elders in the United States on the Uniform Data Set. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 10: S338-43. PMID 24418057 DOI: 10.1016/J.Jalz.2013.09.002  0.376
2014 Dysken MW, Sano M, Asthana S, Vertrees JE, Pallaki M, Llorente M, Love S, Schellenberg GD, McCarten JR, Malphurs J, Prieto S, Chen P, Loreck DJ, Trapp G, Bakshi RS, et al. Effect of vitamin E and memantine on functional decline in Alzheimer disease: the TEAM-AD VA cooperative randomized trial. Jama. 311: 33-44. PMID 24381967 DOI: 10.1001/Jama.2013.282834  0.375
2014 Guerrero-Berroa E, Ravona-Springer R, Schmeidler J, Silverman JM, Sano M, Koifmann K, Preiss R, Hoffman H, Heymann A, Schnaider Beeri M. Age, gender, and education are associated with cognitive performance in an older Israeli sample with type 2 diabetes. International Journal of Geriatric Psychiatry. 29: 299-309. PMID 23925856 DOI: 10.1002/Gps.4008  0.328
2014 Wang S, Luo X, Barnes D, Sano M, Yaffe K. Physical activity and risk of cognitive impairment among oldest-old women. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 22: 1149-57. PMID 23831179 DOI: 10.1016/J.Jagp.2013.03.002  0.367
2014 Dysken MW, Guarino PD, Vertrees JE, Asthana S, Sano M, Llorente M, Pallaki M, Love S, Schellenberg GD, McCarten JR, Malphurs J, Prieto S, Chen P, Loreck DJ, Carney S, et al. Vitamin E and memantine in Alzheimer's disease: clinical trial methods and baseline data. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 10: 36-44. PMID 23583234 DOI: 10.1016/J.Jalz.2013.01.014  0.419
2014 Sano M, Egelko S, Donohue MC, Kaye J, Mundt J, Sun C, Ferris S, Aisen PS. Assessing Clinical Progression For Dementia Prevention Trial: Results From The Hba Trial Alzheimers & Dementia. 10: 138. DOI: 10.1016/J.Jalz.2014.04.084  0.339
2013 Ravona-Springer R, Heymann A, Schmeidler J, Guerrero-Berroa E, Sano M, Preiss R, Koifman K, Hoffman H, Levy A, Silverman JM, Schnaider-Beeri M. Haptoglobin 1-1 genotype is associated with poorer cognitive functioning in the elderly with type 2 diabetes. Diabetes Care. 36: 3139-45. PMID 23990521 DOI: 10.2337/Dc12-2250  0.381
2013 Salmon DP, Ferris SH, Thomas RG, Sano M, Cummings JL, Sperling RA, Petersen RC, Aisen PS. Age and apolipoprotein E genotype influence rate of cognitive decline in nondemented elderly. Neuropsychology. 27: 391-401. PMID 23876113 DOI: 10.1037/A0032707  0.444
2013 Sewell MC, Luo X, Neugroschl J, Sano M. Detection of mild cognitive impairment and early stage dementia with an audio-recorded cognitive scale. International Psychogeriatrics / Ipa. 25: 1325-33. PMID 23635663 DOI: 10.1016/J.Jalz.2013.05.1295  0.421
2013 Zhu CW, Sano M, Ferris SH, Whitehouse PJ, Patterson MB, Aisen PS. Health-related resource use and costs in elderly adults with and without mild cognitive impairment. Journal of the American Geriatrics Society. 61: 396-402. PMID 23414481 DOI: 10.1111/Jgs.12132  0.357
2013 Gandy S, Haroutunian V, DeKosky ST, Sano M, Schadt EE. CR1 and the "vanishing amyloid" hypothesis of Alzheimer's disease. Biological Psychiatry. 73: 393-5. PMID 23399469 DOI: 10.1016/J.Biopsych.2013.01.013  0.372
2013 Zhu CW, Livote EE, Scarmeas N, Albert M, Brandt J, Blacker D, Sano M, Stern Y. Long-term associations between cholinesterase inhibitors and memantine use and health outcomes among patients with Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 9: 733-40. PMID 23332671 DOI: 10.1016/J.Jalz.2012.09.015  0.431
2013 Van Dam NT, Sano M, Mitsis EM, Grossman HT, Gu X, Park Y, Hof PR, Fan J. Functional neural correlates of attentional deficits in amnestic mild cognitive impairment. Plos One. 8: e54035. PMID 23326568 DOI: 10.1371/Journal.Pone.0054035  0.377
2013 Sano M, Egelko S, Donohue M, Ferris S, Kaye J, Hayes TL, Mundt JC, Sun CK, Paparello S, Aisen PS. Developing dementia prevention trials: baseline report of the Home-Based Assessment study. Alzheimer Disease and Associated Disorders. 27: 356-62. PMID 23151596 DOI: 10.1097/Wad.0B013E3182769C05  0.369
2013 Mitsis E, Riggio S, D'Antonio E, Goldstein M, DeKosky S, Naidich T, Delman B, Machac J, Elder G, Sano M, Gandy S, Gordon W. Florbetapir scanning excludes Alzheimer's disease in a retired NFL player with delayed cognitive impairment Alzheimers & Dementia. 9: 373. DOI: 10.1016/J.Jalz.2013.05.726  0.447
2013 Guerrero-Berroa E, Ravona-Springer R, Schmeidler J, Silverman J, Sano M, Koifman K, Preiss R, Hoffman H, Heymann A, Beeri MS. Age, gender and education are associated with cognitive performance in among Israeli elderly individuals with type 2 diabetes Alzheimers & Dementia. 9: 796. DOI: 10.1016/J.Jalz.2013.05.1639  0.328
2013 Geramian H, Neugroschl J, McGovern C, Benson G, Creighton J, Lopez S, Sano M, Luo X, Sewell M. Why they stay: Understanding participant retention in Alzheimer's disease research Alzheimers & Dementia. 9: 649. DOI: 10.1016/J.Jalz.2013.05.1325  0.363
2013 Soleimani l, Lopez S, Fuente ADL, Benson G, Creighton J, Geramain H, McGovern C, Luo X, Sano M, Neugroschl J. Self and proxy ratings of patient-reported outcomes: Impact of cognitive status Alzheimers & Dementia. 9: 491. DOI: 10.1016/J.Jalz.2013.05.1006  0.315
2013 Welsh-Bohmer K, Romero H, Hayden K, Plassman B, Germain C, Sano M, Espeland M, Craft S, Monsch A, Schneider L, Chiang C, Haneline S, Oneil J, Malholtra M, Brannan S, et al. O1-06-01: Challenges in international clinical trials to delay early symptomatic Alzheimer's disease Alzheimer's & Dementia. 9: P137-P138. DOI: 10.1016/J.Jalz.2013.04.079  0.359
2012 Naylor MD, Karlawish JH, Arnold SE, Khachaturian AS, Khachaturian ZS, Lee VM, Baumgart M, Banerjee S, Beck C, Blennow K, Brookmeyer R, Brunden KR, Buckwalter KC, Comer M, Covinsky K, ... ... Sano M, et al. Advancing Alzheimer's disease diagnosis, treatment, and care: recommendations from the Ware Invitational Summit. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 8: 445-52. PMID 22959699 DOI: 10.1016/J.Jalz.2012.08.001  0.349
2012 Silverman JM, Schmeidler J, Beeri MS, Rosendorff C, Sano M, Grossman HT, Carrión-Baralt JR, Bespalova IN, West R, Haroutunian V. C-reactive protein and familial risk for dementia: a phenotype for successful cognitive aging. Neurology. 79: 1116-23. PMID 22895578 DOI: 10.1212/Wnl.0B013E3182698C89  0.402
2012 Nair G, Van Dyk K, Shah U, Purohit DP, Pinto C, Shah AB, Grossman H, Perl D, Ganwir V, Shanker S, Sano M. Characterizing cognitive deficits and dementia in an aging urban population in India. International Journal of Alzheimer's Disease. 2012: 673849. PMID 22792507 DOI: 10.1155/2012/673849  0.373
2012 Irizarry MC, Jin S, He F, Emond JA, Raman R, Thomas RG, Sano M, Quinn JF, Tariot PN, Galasko DR, Ishihara LS, Weil JG, Aisen PS. Incidence of new-onset seizures in mild to moderate Alzheimer disease. Archives of Neurology. 69: 368-72. PMID 22410444 DOI: 10.1001/Archneurol.2011.830  0.394
2012 Post JB, Morin KG, Sano M, Jegede AB, Langhoff E, Spungen AM. Increased presence of cognitive impairment in hemodialysis patients in the absence of neurological events. American Journal of Nephrology. 35: 120-6. PMID 22212437 DOI: 10.1159/000334871  0.397
2012 Beeri MS, Haroutunian V, Schmeidler J, Sano M, Fam P, Kavanaugh A, Barr AM, Honer WG, Katsel P. Synaptic protein deficits are associated with dementia irrespective of extreme old age. Neurobiology of Aging. 33: 1125.e1-8. PMID 22206847 DOI: 10.1016/J.Neurobiolaging.2011.08.017  0.352
2012 Nandipati S, Luo X, Schimming C, Grossman HT, Sano M. Cognition in non-demented diabetic older adults. Current Aging Science. 5: 131-5. PMID 22023096 DOI: 10.2174/1874609811205020131  0.362
2012 Cai G, Atzmon G, Naj AC, Beecham GW, Barzilai N, Haines JL, Sano M, Pericak-Vance M, Buxbaum JD. Evidence against a role for rare ADAM10 mutations in sporadic Alzheimer disease. Neurobiology of Aging. 33: 416-417.e3. PMID 20381196 DOI: 10.1016/J.Neurobiolaging.2010.03.003  0.359
2012 Doody R, Winblad B, Cummings J, Tariot P, Sano M, Aisen P, Selby B, Seely L. Dimebon in Alzheimer's disease: Summary and contrast of three efficacy trials Alzheimers & Dementia. 8: 456. DOI: 10.1016/J.Jalz.2012.05.1217  0.383
2011 Kaufmann P, Engelstad K, Wei Y, Kulikova R, Oskoui M, Sproule DM, Battista V, Koenigsberger DY, Pascual JM, Shanske S, Sano M, Mao X, Hirano M, Shungu DC, Dimauro S, et al. Natural history of MELAS associated with mitochondrial DNA m.3243A>G genotype. Neurology. 77: 1965-71. PMID 22094475 DOI: 10.1212/Wnl.0B013E31823A0C7F  0.316
2011 Beeri MS, Moshier E, Schmeidler J, Godbold J, Uribarri J, Reddy S, Sano M, Grossman HT, Cai W, Vlassara H, Silverman JM. Serum concentration of an inflammatory glycotoxin, methylglyoxal, is associated with increased cognitive decline in elderly individuals. Mechanisms of Ageing and Development. 132: 583-7. PMID 22079406 DOI: 10.1016/J.Mad.2011.10.007  0.335
2011 Greenwood TA, Beeri MS, Schmeidler J, Valerio D, Raventós H, Mora-Villalobos L, Camacho K, Carrión-Baralt JR, Angelo G, Almasy L, Sano M, Silverman JM. Heritability of cognitive functions in families of successful cognitive aging probands from the Central Valley of Costa Rica. Journal of Alzheimer's Disease : Jad. 27: 897-907. PMID 21908911 DOI: 10.3233/Jad-2011-110782  0.372
2011 Sano M, Bell KL, Galasko D, Galvin JE, Thomas RG, van Dyck CH, Aisen PS. A randomized, double-blind, placebo-controlled trial of simvastatin to treat Alzheimer disease. Neurology. 77: 556-63. PMID 21795660 DOI: 10.1212/Wnl.0B013E318228Bf11  0.401
2011 Vigen CL, Mack WJ, Keefe RS, Sano M, Sultzer DL, Stroup TS, Dagerman KS, Hsiao JK, Lebowitz BD, Lyketsos CG, Tariot PN, Zheng L, Schneider LS. Cognitive effects of atypical antipsychotic medications in patients with Alzheimer's disease: outcomes from CATIE-AD. The American Journal of Psychiatry. 168: 831-9. PMID 21572163 DOI: 10.1176/Appi.Ajp.2011.08121844  0.474
2011 Weir DR, Wallace RB, Langa KM, Plassman BL, Wilson RS, Bennett DA, Duara R, Loewenstein D, Ganguli M, Sano M. Reducing case ascertainment costs in U.S. population studies of Alzheimer's disease, dementia, and cognitive impairment-Part 1. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 7: 94-109. PMID 21255747 DOI: 10.1016/j.jalz.2010.11.004  0.304
2011 Purohit DP, Batheja NO, Sano M, Jashnani KD, Kalaria RN, Karunamurthy A, Kaur S, Shenoy AS, Van Dyk K, Schmeidler J, Perl DP. Profiles of Alzheimer's disease-related pathology in an aging urban population sample in India. Journal of Alzheimer's Disease : Jad. 24: 187-96. PMID 21187583 DOI: 10.3233/Jad-2010-101698  0.379
2011 Zhu CW, Livote EE, Kahle-Wrobleski K, Scarmeas N, Albert M, Brandt J, Blacker D, Sano M, Stern Y. Utilization of antihypertensives, antidepressants, antipsychotics, and hormones in Alzheimer disease. Alzheimer Disease and Associated Disorders. 25: 144-8. PMID 20975515 DOI: 10.1097/Wad.0B013E3181Fcba68  0.375
2011 Sano M, Raman R, Emond J, Thomas RG, Petersen R, Schneider LS, Aisen PS. Adding delayed recall to the Alzheimer Disease Assessment Scale is useful in studies of mild cognitive impairment but not Alzheimer disease. Alzheimer Disease and Associated Disorders. 25: 122-7. PMID 20921876 DOI: 10.1097/Wad.0B013E3181F883B7  0.471
2011 Sano M, Egelko S, Ferris S, Kaye J, Hayes T, Mundt J, Reyes T, Donohue M, Sun C, Whitehair D, Stokes K, Aisen P. Alzheimer disease cooperative study (ADCS) home based assessment: Designing trials with new technology Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.1434  0.339
2011 Haroutunian V, Beeri MS, Sano M, Gandy S, Purohit D, Maroukian M, Katsel P. Oligomeric abeta associated with dementia in young-old and oldest-old persons Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.1161  0.301
2010 McLaughlin T, Feldman H, Fillit H, Sano M, Schmitt F, Aisen P, Leibman C, Mucha L, Ryan JM, Sullivan SD, Spackman DE, Neumann PJ, Cohen J, Stern Y. Dependence as a unifying construct in defining Alzheimer's disease severity. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 6: 482-93. PMID 21044778 DOI: 10.1016/J.Jalz.2009.09.004  0.414
2010 Sano M. ICAD 2010: Detection may hold the key to treatment. International Conference on Alzheimer Disease (ICAD) 2010 Honolulu, HI, USA, 10–15 July 2010. Expert Review of Neurotherapeutics. 10: 1659-61. PMID 20977323 DOI: 10.1586/Ern.10.150  0.406
2010 Devier DJ, Villemarette-Pittman N, Brown P, Pelton G, Stern Y, Sano M, Devanand DP. Predictive utility of type and duration of symptoms at initial presentation in patients with mild cognitive impairment. Dementia and Geriatric Cognitive Disorders. 30: 238-44. PMID 20847554 DOI: 10.1159/000320137  0.43
2010 Gauthier S, Garcia A, Sano M, Robert P, Senanarong V, Woodward M, Brodaty H. Priorities for research consortia on Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 6: 359-62. PMID 20630416 DOI: 10.1016/J.Jalz.2010.05.2017  0.388
2010 Zhu CW, Livote EE, Kahle-Wrobleski K, Scarmeas N, Albert M, Brandt J, Blacker D, Sano M, Stern Y. Longitudinal medication usage in Alzheimer disease patients. Alzheimer Disease and Associated Disorders. 24: 354-9. PMID 20625271 DOI: 10.1097/Wad.0B013E3181E6A17A  0.422
2010 Post JB, Jegede AB, Morin K, Spungen AM, Langhoff E, Sano M. Cognitive profile of chronic kidney disease and hemodialysis patients without dementia. Nephron. Clinical Practice. 116: c247-55. PMID 20606486 DOI: 10.1159/000317206  0.42
2010 Sano M, Egelko S, Ferris S, Kaye J, Hayes TL, Mundt JC, Donohue M, Walter S, Sun S, Sauceda-Cerda L. Pilot study to show the feasibility of a multicenter trial of home-based assessment of people over 75 years old. Alzheimer Disease and Associated Disorders. 24: 256-63. PMID 20592583 DOI: 10.1097/Wad.0B013E3181D7109F  0.367
2010 Silverstein JH, Allore HG, Deiner S, Sano M, Rasmussen L. Is Postoperative Cognitive Decline Clinically Relevant Anesthesiology. 112: 1280-1281. PMID 20418703 DOI: 10.1097/Aln.0B013E3181D690A6  0.408
2010 Khachaturian ZS, Barnes D, Einstein R, Johnson S, Lee V, Roses A, Sager MA, Shankle WR, Snyder PJ, Petersen RC, Schellenberg G, Trojanowski J, Aisen P, Albert MS, Breitner JC, ... ... Sano M, et al. Developing a national strategy to prevent dementia: Leon Thal Symposium 2009. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 6: 89-97. PMID 20298968 DOI: 10.1016/J.Jalz.2010.01.008  0.402
2010 Neugroschl J, Sano M. Current treatment and recent clinical research in Alzheimer's disease. Mount Sinai Journal of Medicine. 77: 3-16. PMID 20101716 DOI: 10.1002/Msj.20165  0.351
2010 Mitsis EM, Jacobs D, Luo X, Andrews H, Andrews K, Sano M. Evaluating cognition in an elderly cohort via telephone assessment. International Journal of Geriatric Psychiatry. 25: 531-9. PMID 19697298 DOI: 10.1002/Gps.2373  0.368
2010 Wang S, Jacobs D, Andrews H, Tsai WY, Luo X, Bergmann C, Sano M. Cardiovascular risk and memory in non-demented elderly women. Neurobiology of Aging. 31: 1250-3. PMID 18805604 DOI: 10.1016/J.Neurobiolaging.2008.08.007  0.372
2010 Sano M, Styren S, Fullerton T, Brunell R, Dubrava S, McRae T. Safety and Tolerability of Dimebon for up to 26 Weeks in Patients With Mild to Moderate Alzheimer's Disease Alzheimers & Dementia. 6. DOI: 10.1016/J.Jalz.2010.08.198  0.365
2010 Zhu C, Sano M, Ferris S, Aisen P. Assessing Health Related Resource use in Normal Elders and Subjects With Mild Cognitive Impairment Alzheimers & Dementia. 6. DOI: 10.1016/J.Jalz.2010.08.103  0.344
2010 Sano M, Jacobs D, Luo X, Andrews H, Andrews K, Bell K, Graff-Radford N, Lucas J, Rabins P, Bolla K, Mitsis E. O4-08-02: Prevention of Postmenopausal Alzheimer's Disease and Cognitive Loss with Replacement Estrogen (PREPARE) Study Results Alzheimer's & Dementia. 6: e18-e18. DOI: 10.1016/J.Jalz.2010.08.055  0.405
2010 West B, McKee AC, Sano M, Perl DP. P1-199: Alzheimer's disease and chronic traumatic encephalopathy: An overlapping pathological picture? Alzheimer's & Dementia. 6: S231-S231. DOI: 10.1016/J.Jalz.2010.05.749  0.356
2010 Zhu C, Livote E, Kahle-Wrobleski K, Scarmeas N, Albert M, Brandt J, Blacker D, Sano M, Stern Y. P2-073: Longitudinal patterns of medication use in Alzheimer's disease Alzheimer's & Dementia. 6: S334-S334. DOI: 10.1016/J.Jalz.2010.05.1119  0.337
2010 Sano M, Jacobs D, Gaynor K. Hormone Replacement Therapy and Cognitive Function Principles of Gender-Specific Medicine. 142-148. DOI: 10.1016/B978-0-12-374271-1.00013-7  0.322
2010 Sano M. Tarenflurbil: Mechanisms and myths Archives of Neurology. 67: 750-752. DOI: 10.1001/Archneurol.2010.94  0.436
2009 Steele JW, Kim SH, Cirrito JR, Verges DK, Restivo JL, Westaway D, Fraser P, Hyslop PS, Sano M, Bezprozvanny I, Ehrlich ME, Holtzman DM, Gandy S. Acute dosing of latrepirdine (Dimebon), a possible Alzheimer therapeutic, elevates extracellular amyloid-beta levels in vitro and in vivo. Molecular Neurodegeneration. 4: 51. PMID 20017949 DOI: 10.1186/1750-1326-4-51  0.318
2009 Schneider LS, Sano M. Current Alzheimer's disease clinical trials: methods and placebo outcomes. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 5: 388-97. PMID 19751918 DOI: 10.1016/J.Jalz.2009.07.038  0.364
2009 Zhu CW, Penrod JD, Ross JS, Dellenbaugh C, Sano M. Use of Medicare and Department of Veterans Affairs health care by veterans with dementia: a longitudinal analysis. Journal of the American Geriatrics Society. 57: 1908-14. PMID 19682132 DOI: 10.1111/J.1532-5415.2009.02405.X  0.305
2009 Neugroschl J, Sano M. An update on treatment and prevention strategies for Alzheimer's disease. Current Neurology and Neuroscience Reports. 9: 368-376. PMID 19664366 DOI: 10.1007/S11910-009-0054-1  0.328
2009 Federman AD, Cole H, Sano M. Cognitive performance in community-dwelling English- and Spanish-speaking seniors. Age and Ageing. 38: 669-75. PMID 19651699 DOI: 10.1093/Ageing/Afp127  0.32
2009 Carrión-Baralt JR, Meléndez-Cabrero J, Rodríguez-Ubiñas H, Schmeidler J, Beeri MS, Angelo G, Sano M, Silverman JM. Impact of APOE epsilon4 on the cognitive performance of a sample of non-demented Puerto Rican nonagenarians. Journal of Alzheimer's Disease : Jad. 18: 533-40. PMID 19584451 DOI: 10.3233/Jad-2009-1160  0.415
2009 Zhu CW, Leibman C, Townsend R, McLaughlin T, Scarmeas N, Albert M, Brandt J, Blacker D, Sano M, Stern Y. Bridging from clinical endpoints to estimates of treatment value for external decision makers. The Journal of Nutrition, Health & Aging. 13: 256-9. PMID 19262963 DOI: 10.1007/S12603-009-0068-Z  0.354
2009 Gandy S, Cirrito J, Steele J, Kim SH, Thinakaran G, Westaway D, Fraser P, St George Hyslop P, Sano M, Bezprozvanny I, Ehrlich ME, Holtzman DM. S4-04-06: Dimebon®: A Clinically Promising Drug for Alzheimer's Disease, Regulates Amyloid-Beta Metabolism in Cultured Cells, In Isolated Nerve Terminals, and In the Interstitial Fluid of the Living Rodent Brain Alzheimer's & Dementia. 5: e5-e5. DOI: 10.1016/J.Jalz.2009.07.133  0.303
2009 Zhu CW, Kahle-Wrobleski K, Livote E, Scarmeas N, Albert M, Brandt J, Blacker D, Sano M, Stern Y. Longitudinal medication usage in Alzheimer's disease patients Alzheimers & Dementia. 5: 407. DOI: 10.1016/J.Jalz.2009.04.990  0.358
2009 Grossman H, Marzloff G, Luo X, LeRoith D, Sano M, Pasinetti G. P1-279: NIC5-15 as a treatment for Alzheimer's: Safety, pharmacokinetics and clinical variables Alzheimer's & Dementia. 5: P259-P259. DOI: 10.1016/J.Jalz.2009.04.287  0.319
2008 Zhu CW, Leibman C, McLaughlin T, Zbrozek AS, Scarmeas N, Albert M, Brandt J, Blacker D, Sano M, Stern Y. Patient dependence and longitudinal changes in costs of care in Alzheimer's disease. Dementia and Geriatric Cognitive Disorders. 26: 416-23. PMID 18946219 DOI: 10.1159/000164797  0.336
2008 Aisen PS, Schneider LS, Sano M, Diaz-Arrastia R, van Dyck CH, Weiner MF, Bottiglieri T, Jin S, Stokes KT, Thomas RG, Thal LJ. High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial. Jama. 300: 1774-83. PMID 18854539 DOI: 10.1001/Jama.300.15.1774  0.363
2008 Sano M, Grossman H, Dyk KV. Preventing Alzheimer's disease : separating fact from fiction. Cns Drugs. 22: 887-902. PMID 18840031 DOI: 10.2165/00023210-200822110-00001  0.368
2008 Sano M, Jacobs D, Andrews H, Bell K, Graff-Radford N, Lucas J, Rabins P, Bolla K, Tsai WY, Cross P, Andrews K, Costa R, Xiaodong Luo. A multi-center, randomized, double blind placebo-controlled trial of estrogens to prevent Alzheimer's disease and loss of memory in women: design and baseline characteristics. Clinical Trials (London, England). 5: 523-33. PMID 18827045 DOI: 10.1177/1740774508096313  0.386
2008 Rottnek M, Riggio S, Byne W, Sano M, Margolis RL, Walker RH. Schizophrenia in a patient with spinocerebellar ataxia 2: coincidence of two disorders or a neurodegenerative disease presenting with psychosis? The American Journal of Psychiatry. 165: 964-7. PMID 18676601 DOI: 10.1176/Appi.Ajp.2008.08020285  0.322
2008 Doody RS, Gavrilova SI, Sano M, Thomas RG, Aisen PS, Bachurin SO, Seely L, Hung D. Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled study. Lancet (London, England). 372: 207-15. PMID 18640457 DOI: 10.1016/S0140-6736(08)61074-0  0.447
2008 Zhu CW, Scarmeas N, Stavitsky K, Albert M, Brandt J, Blacker D, Sano M, Stern Y. Comparison of costs of care between patients with Alzheimer's disease and dementia with Lewy bodies. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 4: 280-4. PMID 18631979 DOI: 10.1016/J.Jalz.2008.02.008  0.404
2008 Khachaturian ZS, Petersen RC, Gauthier S, Buckholtz N, Corey-Bloom JP, Evans B, Fillit H, Foster N, Greenberg B, Grundman M, Sano M, Simpkins J, Schneider LS, Weiner MW, Galasko D, et al. A roadmap for the prevention of dementia: the inaugural Leon Thal Symposium. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 4: 156-63. PMID 18631960 DOI: 10.1016/J.Jalz.2008.03.005  0.397
2008 Zhu CW, Torgan R, Scarmeas N, Albert M, Brandt J, Blacker D, Sano M, Stern Y. Home health and informal care utilization and costs over time in Alzheimer's disease. Home Health Care Services Quarterly. 27: 1-20. PMID 18510196 DOI: 10.1300/J027V27N01_01  0.303
2008 Rapp MA, Schnaider-Beeri M, Purohit DP, Perl DP, Haroutunian V, Sano M. Increased neurofibrillary tangles in patients with Alzheimer disease with comorbid depression. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 16: 168-74. PMID 18239198 DOI: 10.1097/Jgp.0B013E31816029Ec  0.375
2008 Sano M, Ferris S, Kaye J, Hayes TL, Mundt JC, Yan L, Sun S, Egelko S, Walter S. P1-381: Pilot study to assess reliability and efficiency of home-based assessment for dementia prevention trials Alzheimers & Dementia. 4. DOI: 10.1016/J.Jalz.2008.05.963  0.333
2008 Sano M. S5-01-05: Multi-center, randomized, double-blind, placebo-controlled trial of Simvastatin to slow the progression of Alzheimer's disease Alzheimers & Dementia. 4. DOI: 10.1016/J.Jalz.2008.05.562  0.366
2008 Zhu C, Leibman C, McLaughlin T, Scarmeas N, Albert M, Brandt J, Blacker D, Sano M, Stern Y. O2-07-05: Patient dependence, function, and changes in cost of care in Alzheimer's disease Alzheimer's & Dementia. 4: T147-T147. DOI: 10.1016/J.Jalz.2008.05.362  0.317
2008 Raman R, Emond J, Thomas RG, Petersen RC, Schneider LS, Aisen PS, Sano M. P4-387: Adding delayed recall to the Alzheimer's disease assessment scale-cognitive subscale (ADAS-cog): Sensitivity in a clinical trial for Alzheimer's disease and mild cognitive impairment Alzheimer's & Dementia. 4: T787-T788. DOI: 10.1016/J.Jalz.2008.05.2457  0.484
2008 Dysken M, Guarino P, Love SB, Asthana S, Sano M, Llorente M, Vertrees J, Vatassery G, Schellenberg G, Tomaska J. P4-363: A randomized clinical trial of vitamin E and memantine in Alzheimer's disease Alzheimers & Dementia. 4. DOI: 10.1016/J.Jalz.2008.05.2434  0.358
2008 Zhu C, Scarmeas N, Albert M, Brandt J, Blacker D, Sano M, Stern Y. AbstractPoster presentation: Tuesday posterP3-442: Comparison of costs of care between patients with Alzheimer's disease and dementia with Lewy bodies Alzheimers & Dementia. 4. DOI: 10.1016/J.Jalz.2008.05.2012  0.366
2008 Carrion-Baralt JR, Schnaider-Beeri M, Melendez-Cabrero J, Rodriguez-Ubiñas H, Sano M, Silverman JM. P3-285: Impact of APOE ϵ4 on very late life cognition Alzheimers & Dementia. 4. DOI: 10.1016/J.Jalz.2008.05.1853  0.351
2007 Beekly DL, Ramos EM, Lee WW, Deitrich WD, Jacka ME, Wu J, Hubbard JL, Koepsell TD, Morris JC, Kukull WA, Reiman EM, Kowall N, Landreth G, Shelanski M, Welsh-Bohmer K, ... ... Sano M, et al. The National Alzheimer's Coordinating Center (NACC) database: The uniform data set Alzheimer Disease and Associated Disorders. 21: 249-258. PMID 17804958 DOI: 10.1097/Wad.0B013E318142774E  0.368
2007 Faison WE, Schultz SK, Aerssens J, Alvidrez J, Anand R, Farrer LA, Jarvik L, Manly J, McRae T, Murphy GM, Olin JT, Regier D, Sano M, Mintzer JE. Potential ethnic modifiers in the assessment and treatment of Alzheimer's disease: challenges for the future. International Psychogeriatrics / Ipa. 19: 539-58. PMID 17451614 DOI: 10.1017/S104161020700511X  0.414
2007 Dyk KV, Sano M. The impact of nutrition on cognition in the elderly. Neurochemical Research. 32: 893-904. PMID 17342414 DOI: 10.1007/S11064-006-9241-5  0.346
2007 Wang S, Jacobs D, Andrews H, Tsai W, Luo X, Bergmann C, Sano M. O1-01-05: An association between cardiovascular risk and cognitive status in non-demented elderly women with a family history of Alzheimer's disease Alzheimer's & Dementia. 3: S167-S167. DOI: 10.1016/J.Jalz.2007.04.359  0.382
2006 Zhu CW, Sano M. Economic considerations in the management of Alzheimer's disease. Clinical Interventions in Aging. 1: 143-154. PMID 18044111 DOI: 10.2147/Ciia.2006.1.2.143  0.31
2006 Sano M, Zhu CW, Whitehouse PJ, Edland S, Jin S, Ernstrom K, Thomas RG, Thal LJ, Ferris SH. ADCS Prevention Instrument Project: pharmacoeconomics: assessing health-related resource use among healthy elderly. Alzheimer Disease and Associated Disorders. 20: S191-202. PMID 17135812 DOI: 10.1097/01.Wad.0000213875.63171.87  0.442
2006 Patterson MB, Whitehouse PJ, Edland SD, Sami SA, Sano M, Smyth K, Weiner MF. ADCS Prevention Instrument Project: quality of life assessment (QOL). Alzheimer Disease and Associated Disorders. 20: S179-90. PMID 17135811 DOI: 10.1097/01.Wad.0000213874.25053.E5  0.316
2006 Galasko D, Bennett DA, Sano M, Marson D, Kaye J, Edland SD. ADCS Prevention Instrument Project: assessment of instrumental activities of daily living for community-dwelling elderly individuals in dementia prevention clinical trials. Alzheimer Disease and Associated Disorders. 20: S152-69. PMID 17135809 DOI: 10.1097/01.Wad.0000213873.25053.2B  0.387
2006 Salmon DP, Cummings JL, Jin S, Sano M, Sperling RA, Zamrini E, Petersen RC, Edland SD, Thal LJ, Ferris SH. ADCS Prevention Instrument Project: development of a brief verbal memory test for primary prevention clinical trials. Alzheimer Disease and Associated Disorders. 20: S139-46. PMID 17135807 DOI: 10.1097/01.Wad.0000213871.40300.68  0.33
2006 Ferris SH, Aisen PS, Cummings J, Galasko D, Salmon DP, Schneider L, Sano M, Whitehouse PJ, Edland S, Thal LJ. ADCS Prevention Instrument Project: overview and initial results. Alzheimer Disease and Associated Disorders. 20: S109-23. PMID 17135805 DOI: 10.1097/01.Wad.0000213870.40300.21  0.435
2006 Sano M, Egelko S, Jin S, Cummings J, Clark CM, Pawluczyk S, Thomas RJ, Schittini M, Thal LJ. Spanish instrument protocol: new treatment efficacy instruments for Spanish-speaking patients in Alzheimer disease clinical trials. Alzheimer Disease and Associated Disorders. 20: 232-41. PMID 17132967 DOI: 10.1097/01.Wad.0000213862.20108.F5  0.448
2006 Zhu CW, Scarmeas N, Torgan R, Albert M, Brandt J, Blacker D, Sano M, Stern Y. Clinical characteristics and longitudinal changes of informal cost of Alzheimer's disease in the community. Journal of the American Geriatrics Society. 54: 1596-602. PMID 17038080 DOI: 10.1111/J.1532-5415.2006.00871.X  0.349
2006 Bergmann C, Sano M. Cardiac risk factors and potential treatments in Alzheimer's disease. Neurological Research. 28: 595-604. PMID 16945210 DOI: 10.1179/016164106X130498  0.428
2006 Zhu CW, Scarmeas N, Torgan R, Albert M, Brandt J, Blacker D, Sano M, Stern Y. Longitudinal study of effects of patient characteristics on direct costs in Alzheimer disease. Neurology. 67: 998-1005. PMID 16914696 DOI: 10.1212/01.Wnl.0000230160.13272.1B  0.346
2006 Sano M. Neuropsychological testing in the diagnosis of dementia Journal of Geriatric Psychiatry and Neurology. 19: 155-159. PMID 16880357 DOI: 10.1177/0891988706291086  0.395
2006 Zhu CW, Scarmeas N, Torgan R, Albert M, Brandt J, Blacker D, Sano M, Stern Y. Clinical features associated with costs in early AD: baseline data from the Predictors Study. Neurology. 66: 1021-8. PMID 16606913 DOI: 10.1212/01.Wnl.0000204189.18698.C7  0.328
2006 Rapp MA, Schnaider-Beeri M, Grossman HT, Sano M, Perl DP, Purohit DP, Gorman JM, Haroutunian V. Increased hippocampal plaques and tangles in patients with Alzheimer disease with a lifetime history of major depression. Archives of General Psychiatry. 63: 161-7. PMID 16461859 DOI: 10.1001/Archpsyc.63.2.161  0.349
2006 Beeri MS, Vlassara H, Sano M, Uribarri J, Schmeidler J, Wallenstein S, Cai W, Wang J, Lally R, West R, Chen X, Grossman HT, Silverman JM. Serum Advanced Glycation Endproducts (AGE) Correlate With Cognition in the Very Elderly Alzheimer Disease & Associated Disorders. 20. DOI: 10.1097/00002093-200607001-00016  0.346
2006 Beeri MS, Vlassara H, Sano M, Schmeidler J, Cai W, Wang J, Lally R, Grossman HT, Silverman JM. P1-214: Advanced glycation is associated with cognitive impairment in very old women Alzheimers & Dementia. 2. DOI: 10.1016/J.Jalz.2006.05.591  0.347
2006 Edland SD, Schnaider-Beeri M, Raventos H, Aguilar DV, Campos LEC, Castro MP, Angelo GW, Grossman HT, Bespalova IN, Sano M, Silverman JM. P1-206: The search for a successful cognitive aging endophenotype in the offspring of very elderly (90+) nondemented probands in a founder population Alzheimers & Dementia. 2. DOI: 10.1016/J.Jalz.2006.05.583  0.34
2006 Purohit DP, Pinto C, Perl DP, Shah AB, Deshpande J, Shinde S, Karande SS, Sano M. P1-169: Clinical and neuropathologic studies of age-related cognitive loss in Mumbai, India Alzheimers & Dementia. 2. DOI: 10.1016/J.Jalz.2006.05.545  0.369
2006 Emond JA, Jin S, Bochenek J, Thal LJ, Petersen RC, Sano M, Edland SD. P3-120: Predictors of dropout in clinical trials of subjects with mild cognitive impairment (MCI) Alzheimer's & Dementia. 2: S409-S409. DOI: 10.1016/J.Jalz.2006.05.1388  0.399
2005 Sano M, Amatniek J, Feely M, Sinyak F, Holton D, Ascher S, Finkel SI. Undertreatment of patients with Alzheimer's disease in an elderly United States population. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 1: 136-44. PMID 19595846 DOI: 10.1016/J.Jalz.2005.09.011  0.397
2005 Rapp MA, Schnaider-Beeri M, Sano M, Silverman JM, Haroutunian V. Cross-domain variability of cognitive performance in very old nursing home residents and community dwellers: relationship to functional status. Gerontology. 51: 206-12. PMID 15832049 DOI: 10.1159/000083995  0.35
2005 Petersen RC, Thomas RG, Grundman M, Bennett D, Doody R, Ferris S, Galasko D, Jin S, Kaye J, Levey A, Pfeiffer E, Sano M, van Dyck CH, Thal LJ. Vitamin E and donepezil for the treatment of mild cognitive impairment. The New England Journal of Medicine. 352: 2379-88. PMID 15829527 DOI: 10.1056/Nejmoa050151  0.462
2005 Sano M, Aisen PS, Dalton AJ, Andrews HF, Tsai W. Assessment of Aging Individuals with Down Syndrome in Clinical Trials: Results of Baseline Measures Journal of Policy and Practice in Intellectual Disabilities. 2: 126-138. DOI: 10.1111/J.1741-1130.2005.00021.X  0.413
2005 Aisen PS, Dalton AJ, Sano M, Lott IT, Andrews HF, Tsai W-. Design and Implementation of a Multicenter Trial of Vitamin E in Aging Individuals with Down Syndrome Journal of Policy and Practice in Intellectual Disabilities. 2: 86-93. DOI: 10.1111/J.1741-1130.2005.00020.X  0.352
2005 Rapp MA, Beeri MS, Schmeidler J, Sano M, Silverman JM, Haroutunian V. Relationship of neuropsychological performance to functional status in nursing home residents and community-dwelling older adults. American Journal of Geriatric Psychiatry. 13: 450-459. DOI: 10.1097/00019442-200506000-00003  0.34
2005 Sano M, Jacobs DM, Bell KL, Andrews HF, Tsai W, Lucas JA, Graff-Radford NR, Bolla KI, Rabins P. Using family history to enrich recruitment in prevention trials: Does relative’s age matter? Alzheimers & Dementia. 1. DOI: 10.1016/J.Jalz.2005.06.339  0.316
2005 Sano M, Aisen P, Andrews H, Dalton A. Developing outcome measures for therapeutic trials for dementia in aging individuals with Down Syndrome Alzheimers & Dementia. 1. DOI: 10.1016/J.Jalz.2005.06.290  0.313
2004 Sano M. A guide to diagnosis of Alzheimer's disease Cns Spectrums. 9: 16-19. PMID 15338528 DOI: 10.1017/S1092852900024767  0.446
2004 Grundman M, Petersen RC, Ferris SH, Thomas RG, Aisen PS, Bennett DA, Foster NL, Jack CR, Galasko DR, Doody R, Kaye J, Sano M, Mohs R, Gauthier S, Kim HT, et al. Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. Archives of Neurology. 61: 59-66. PMID 14732621 DOI: 10.1001/Archneur.61.1.59  0.466
2003 Sano M. Current Concepts in the Prevention of Alzheimer's Disease Cns Spectrums. 8: 846-853. PMID 14702007 DOI: 10.1017/S1092852900019283  0.412
2003 Sano M, Wilcock GK, van Baelen B, Kavanagh S. The effects of galantamine treatment on caregiver time in Alzheimer's disease. International Journal of Geriatric Psychiatry. 18: 942-50. PMID 14533127 DOI: 10.1002/Gps.1000  0.381
2003 Pappolla MA, Bryant-Thomas TK, Herbert D, Pacheco J, Fabra Garcia M, Manjon M, Girones X, Henry TL, Matsubara E, Zambon D, Wolozin B, Sano M, Cruz-Sanchez FF, Thal LJ, Petanceska SS, et al. Mild hypercholesterolemia is an early risk factor for the development of Alzheimer amyloid pathology. Neurology. 61: 199-205. PMID 12874399 DOI: 10.1212/01.Wnl.0000070182.02537.84  0.328
2003 Aisen PS, Schafer KA, Grundman M, Pfeiffer E, Sano M, Davis KL, Farlow MR, Jin S, Thomas RG, Thal LJ. Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial. Jama. 289: 2819-26. PMID 12783912 DOI: 10.1001/Jama.289.21.2819  0.455
2003 Thal LJ, Thomas RG, Mulnard R, Sano M, Grundman M, Schneider L. Estrogen levels do not correlate with improvement in cognition. Archives of Neurology. 60: 209-12. PMID 12580705 DOI: 10.1001/Archneur.60.2.209  0.356
2003 Aisen PS, Berg JD, Craft S, Peskind ER, Sano M, Teri L, Mulnard RA, Thomas RG, Thal LJ. Steroid-induced elevation of glucose in Alzheimer's disease: relationship to gender, apolipoprotein E genotype and cognition. Psychoneuroendocrinology. 28: 113-20. PMID 12445840 DOI: 10.1016/S0306-4530(02)00015-X  0.331
2003 Aisen PS, Egelko S, Andrews H, Diaz-Arrastia R, Weiner M, DeCarli C, Jagust W, Miller JW, Green R, Bell K, Sano M. A Pilot Study of Vitamins to Lower Plasma Homocysteine Levels in Alzheimer Disease The American Journal of Geriatric Psychiatry. 11: 246-249. DOI: 10.1097/00019442-200303000-00016  0.333
2002 Sano M. Do dietary antioxidants prevent Alzheimer's disease? Lancet Neurol. 1: 342. PMID 12849394 DOI: 10.1016/S1474-4422(02)00158-8  0.365
2002 Sano M, Bell K, Jacobs D. Cognitive effects of estrogens in women with cardiac disease: what we do not know. The American Journal of Medicine. 113: 612-613. PMID 12459411 DOI: 10.1016/S0002-9343(02)01386-4  0.431
2002 Desmond DW, Moroney JT, Sano M, Stern Y. Mortality in patients with dementia after ischemic stroke. Neurology. 59: 537-43. PMID 12196645 DOI: 10.1212/Wnl.59.4.537  0.31
2002 Sano M. Prevention of Alzheimer's disease: where we stand Current Neurology and Neuroscience Reports. 2: 392-399. PMID 12169218 DOI: 10.1007/S11910-002-0064-8  0.376
2002 Pappolla MA, Smith MA, Bryant-Thomas T, Bazan N, Petanceska S, Perry G, Thal LJ, Sano M, Refolo LM. Cholesterol, oxidative stress, and Alzheimer's disease: expanding the horizons of pathogenesis. Free Radical Biology & Medicine. 33: 173-81. PMID 12106813 DOI: 10.1016/S0891-5849(02)00841-9  0.334
2002 Weiner MF, Tractenberg RE, Sano M, Logsdon R, Teri L, Galasko D, Gamst A, Thomas R, Thal LJ. No long-term effect of behavioral treatment on psychotropic drug use for agitation in Alzheimer's disease patients. Journal of Geriatric Psychiatry and Neurology. 15: 95-8. PMID 12083600 DOI: 10.1177/089198870201500208  0.35
2001 Albert SM, Jacobs DM, Sano M, Marder K, Bell K, Devanand D, Brandt J, Albert M, Stern Y. Longitudinal Study of Quality of Life in People with Advanced Alzheimer's Disease The American Journal of Geriatric Psychiatry. 9: 160-168. DOI: 10.1097/00019442-200105000-00008  0.407
2000 Teri L, Logsdon RG, Peskind E, Raskind M, Weiner MF, Tractenberg RE, Foster NL, Schneider LS, Sano M, Whitehouse P, Tariot P, Mellow AM, Auchus AP, Grundman M, Thomas RG, et al. Treatment of agitation in AD: a randomized, placebo-controlled clinical trial. Neurology. 55: 1271-8. PMID 11087767 DOI: 10.1212/Wnl.55.9.1271  0.373
2000 Marder K, Sano M. Estrogen to treat Alzheimer's disease: too little, too late? So what's a woman to do? Neurology. 54: 2035-7. PMID 10851358 DOI: 10.1212/Wnl.54.11.2035  0.357
2000 Thomas RG, Berg JD, Sano M, Thal L. Analysis of longitudinal data in an Alzheimer's disease clinical trial. Statistics in Medicine. 19: 1433-40. PMID 10844708 DOI: 10.1002/(Sici)1097-0258(20000615/30)19:11/12<1433::Aid-Sim435>3.0.Co;2-F  0.432
2000 Mulnard RA, Cotman CW, Kawas C, Dyck CHv, Sano M, Doody R, Koss E, Pfeiffer E, Jin S, Gamst A, Grundman M, Thomas R. Estrogen Replacement Therapy for Treatment of Mild to Moderate Alzheimer Disease: A Randomized Controlled Trial Obstetrical & Gynecological Survey. 439-440. DOI: 10.1097/00006254-200007000-00021  0.347
2000 Galasko DR, Schmitt FA, Jin S, Saxton J, Bennett D, Sano M, Ferris SH. Detailed assessment of cognition and activities of daily living in moderate to severe Alzheimer's disease Neurobiology of Aging. 21: 168. DOI: 10.1016/S0197-4580(00)82096-5  0.442
2000 Andrews HF, Segal G, Shah C, Mayeux R, Sano M, Jacobs D. Web-based screening, data entry and data management in Alzheimer's disease research Neurobiology of Aging. 21: 160. DOI: 10.1016/S0197-4580(00)82059-X  0.304
1999 Desmond DW, Erkinjuntti T, Sano M, Cummings JL, Bowler JV, Pasquier F, Moroney JT, Ferris SH, Stern Y, Sachdev PS, Hachinski VC. The cognitive syndrome of vascular dementia: implications for clinical trials. Alzheimer Disease and Associated Disorders. 13: S21-9. PMID 10609678 DOI: 10.1097/00002093-199912001-00005  0.444
1999 Jacobs DM, Albert SM, Sano M, del Castillo-Castañeda C, Paik MC, Marder K, Bell K, Brandt J, Albert MS, Stern Y. Assessment of cognition in advanced AD: the test for severe impairment. Neurology. 52: 1689-91. PMID 10331701 DOI: 10.1212/Wnl.52.8.1689  0.411
1999 Manly JJ, Jacobs DM, Sano M, Bell K, Merchant CA, Small SA, Stern Y. Effect of literacy on neuropsychological test performance in nondemented, education-matched elders. Journal of the International Neuropsychological Society : Jins. 5: 191-202. PMID 10217919 DOI: 10.1017/S135561779953302X  0.349
1999 Knopman DS, Berg JD, Thomas R, Grundman M, Thal LJ, Sano M. Nursing home placement is related to dementia progression: experience from a clinical trial. Alzheimer's Disease Cooperative Study. Neurology. 52: 714-8. PMID 10078715 DOI: 10.1212/Wnl.52.4.714  0.422
1999 Olin J, Papka M, Jin S, Sano M, Grundman M, Thomas R. Clinical symptoms of dementia with Lewy bodies: Secondary analyses of the Alzheimer's disease cooperative study selegiline and vitamin E clinical trial European Neuropsychopharmacology. 9: 323. DOI: 10.1016/S0924-977X(99)80444-1  0.377
1998 Whitehouse PJ, Kittner B, Roessner M, Rossor M, Sano M, Thal L, Winblad B. Clinical trial designs for demonstrating disease-course-altering effects in dementia. Alzheimer Disease and Associated Disorders. 12: 281-94. PMID 9876956 DOI: 10.1097/00002093-199812000-00007  0.438
1998 Manly JJ, Jacobs DM, Sano M, Bell K, Merchant CA, Small SA, Stern Y. Cognitive test performance among nondemented elderly African Americans and whites. Neurology. 50: 1238-45. PMID 9595969 DOI: 10.1212/Wnl.50.5.1238  0.314
1998 Marder K, Tang MX, Alfaro B, Mejia H, Cote L, Jacobs D, Stern Y, Sano M, Mayeux R. Postmenopausal estrogen use and Parkinson's disease with and without dementia. Neurology. 50: 1141-3. PMID 9566410 DOI: 10.1212/Wnl.50.4.1141  0.362
1998 Jacobs DM, Tang MX, Stern Y, Sano M, Marder K, Bell KL, Schofield P, Dooneief G, Gurland B, Mayeux R. Cognitive function in nondemented older women who took estrogen after menopause. Neurology. 50: 368-73. PMID 9484355 DOI: 10.1212/Wnl.50.2.368  0.36
1998 Desmond DW, Moroney JT, Bagiella E, Sano M, Stern Y. Dementia as a predictor of adverse outcomes following stroke: An evaluation of diagnostic methods Stroke. 29: 69-74. PMID 9445331 DOI: 10.1161/01.Str.29.1.69  0.347
1998 STERN Y, TANG M, JACOBS DM, SANO M, MARDER K, BELL K, DOONEIEF G, SCHOFIELD P, CÔTÉ L. Prospective comparative study of the evolution of probable Alzheimer's disease and Parkinson's disease dementia Journal of the International Neuropsychological Society. 4: 279-284. DOI: 10.1017/S1355617798002793  0.393
1998 BERG J, THOMAS R, THAL L, SANO M. Measuring cognitive progression in Alzheimer's disease Controlled Clinical Trials. 19: S57-S58. DOI: 10.1016/S0197-2456(98)80152-9  0.444
1997 Sano M, Rosen W, Stern Y, Rosen J, Mayeux R. Simple reaction time as a measure of global attention in Alzheimer's disease. Journal of the International Neuropsychological Society : Jins. 1: 56-61. PMID 9375209 DOI: 10.1017/S1355617700000102  0.379
1997 Jacobs DM, Sano M, Albert S, Schofield P, Dooneief G, Stern Y. Cross-cultural neuropsychological assessment: a comparison of randomly selected, demographically matched cohorts of English- and Spanish-speaking older adults. Journal of Clinical and Experimental Neuropsychology. 19: 331-9. PMID 9268808 DOI: 10.1080/01688639708403862  0.306
1997 Albert SM, Sano M, Marder K, Jacobs DM, Brandt J, Albert M, Stern Y. Participation in clinical trials and long-term outcomes in Alzheimer's disease. Neurology. 49: 38-43. PMID 9222167 DOI: 10.1212/Wnl.49.1.38  0.377
1997 Morris JC, Ernesto C, Schafer K, Coats M, Leon S, Sano M, Thal LJ, Woodbury P. Clinical dementia rating training and reliability in multicenter studies: the Alzheimer's Disease Cooperative Study experience. Neurology. 48: 1508-10. PMID 9191756 DOI: 10.1212/Wnl.48.6.1508  0.385
1997 Stern Y, Brandt J, Albert M, Jacobs DM, Liu X, Bell K, Marder K, Sano M, Albert S, Del-Castillo Castenada C, Bylsma F, Tycko B, Mayeux R. The absence of an apolipoprotein epsilon4 allele is associated with a more aggressive form of Alzheimer's disease. Annals of Neurology. 41: 615-20. PMID 9153523 DOI: 10.1002/Ana.410410510  0.382
1997 Schofield PW, Marder K, Dooneief G, Jacobs DM, Sano M, Stern Y. Association of subjective memory complaints with subsequent cognitive decline in community-dwelling elderly individuals with baseline cognitive impairment. The American Journal of Psychiatry. 154: 609-15. PMID 9137114 DOI: 10.1176/Ajp.154.5.609  0.353
1997 Sano M, Ernesto C, Thomas RG, Klauber MR, Schafer K, Grundman M, Woodbury P, Growdon J, Cotman CW, Pfeiffer E, Schneider LS, Thal LJ. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study. The New England Journal of Medicine. 336: 1216-22. PMID 9110909 DOI: 10.1056/Nejm199704243361704  0.382
1997 Devanand DP, Jacobs DM, Tang MX, Del Castillo-Castaneda C, Sano M, Marder K, Bell K, Bylsma FW, Brandt J, Albert M, Stern Y. The course of psychopathologic features in mild to moderate Alzheimer disease. Archives of General Psychiatry. 54: 257-63. PMID 9075466 DOI: 10.1001/Archpsyc.1997.01830150083012  0.37
1997 Stern Y, Tang MX, Albert MS, Brandt J, Jacobs DM, Bell K, Marder K, Sano M, Devanand D, Albert SM, Bylsma F, Tsai WY. Predicting time to nursing home care and death in individuals with Alzheimer disease. Jama. 277: 806-12. PMID 9052710 DOI: 10.1001/Jama.1997.03540340040030  0.346
1997 Schofield PW, Tang M, Marder K, Bell K, Dooneief G, Chun M, Sano M, Stern Y, Mayeux R. Alzheimer's disease after remote head injury: an incidence study. Journal of Neurology, Neurosurgery, and Psychiatry. 62: 119-24. PMID 9048710 DOI: 10.1136/Jnnp.62.2.119  0.346
1997 Jacobs DM, Sano M, Dooneief G, Marder K, Bell KL, Stern Y. Reply from the Authors: Preclinical AD Neurology. 48: 549-550. DOI: 10.1212/Wnl.48.2.549-C  0.415
1997 Jacobs DM, Marder K, Cote LJ, Sano M, Stern Y, Mayeux R. Reply from the Authors: Early frontal impairment as a predictor of dementia in Parkinson's disease Neurology. 48: 547-547. DOI: 10.1212/Wnl.48.2.547  0.378
1997 Galasko D, Bennett D, Sano M, Ernesto C, Thomas R, Grundman M, Ferris S. An Inventory to Assess Activities of Daily Living for Clinical Trials in Alzheimerʼs Disease Alzheimer Disease & Associated Disorders. 11: 33-39. DOI: 10.1097/00002093-199700112-00005  0.409
1997 Mohs RC, Knopman D, Petersen RC, Ferris SH, Ernesto C, Grundman M, Sano M, Bieliauskas L, Geldmacher D, Clark C, Thal LJ. Development of cognitive instruments for use in clinical trials of antidementia drugs: Additions to the Alzheimer's Disease Assessment Scale that broaden its scope. Alzheimer Disease & Associated Disorders. 11: 13-21. DOI: 10.1097/00002093-199700112-00003  0.444
1997 Ferris SH, Mackell JA, Mohs R, Schneider LS, Galasko D, Whitehouse PJ, Schmitt FA, Sano M, Thomas RG, Ernesto C, Grundman M, Schafer K, Thal LJ. A Multicenter Evaluation of New Treatment Efficacy Instruments for Alzheimerʼs Disease Clinical Trials Alzheimer Disease & Associated Disorders. 11: 1-12. DOI: 10.1097/00002093-199700112-00002  0.31
1996 Thal LJ, Schwartz G, Sano M, Weiner M, Knopman D, Harrell L, Bodenheimer S, Rossor M, Philpot M, Schor J, Goldberg A. A multicenter double-blind study of controlled-release physostigmine for the treatment of symptoms secondary to Alzheimer's disease. Physostigmine Study Group. Neurology. 47: 1389-95. PMID 8960716 DOI: 10.1212/Wnl.47.6.1389  0.407
1996 Stern Y, Liu X, Albert M, Brandt J, Jacobs DM, Del Castillo-Castaneda C, Marder K, Bell K, Sano M, Bylsma F. Modeling the influence of extrapyramidal signs on the progression of Alzheimer disease. Archives of Neurology. 53: 1121-6. PMID 8912485 DOI: 10.1001/Archneur.1996.00550110061013  0.375
1996 Albert SM, Del Castillo-Castaneda C, Sano M, Jacobs DM, Marder K, Bell K, Bylsma F, Lafleche G, Brandt J, Albert M, Stern Y. Quality of life in patients with Alzheimer's disease as reported by patient proxies. Journal of the American Geriatrics Society. 44: 1342-7. PMID 8909350 DOI: 10.1111/J.1532-5415.1996.Tb01405.X  0.314
1996 Sano M, Ernesto C, Klauber MR, Schafer K, Woodbury P, Thomas R, Grundman M, Growdon J, Thal LJ. Rationale and design of a multicenter study of selegiline and alpha-tocopherol in the treatment of Alzheimer disease using novel clinical outcomes. Alzheimer's Disease Cooperative Study. Alzheimer Disease and Associated Disorders. 10: 132-40. PMID 8876776 DOI: 10.1097/00002093-199601030-00004  0.426
1996 Desmond DW, Moroney JT, Sano M, Stern Y. Recovery of cognitive function after stroke. Stroke. 27: 1798-803. PMID 8841333 DOI: 10.1161/01.Str.27.10.1798  0.325
1996 Thal LJ, Carta A, Clarke WR, Ferris SH, Friedland RP, Petersen RC, Pettegrew JW, Pfeiffer E, Raskind MA, Sano M, Tuszynski MH, Woolson RF. A 1-year multicenter placebo-controlled study of acetyl-L-carnitine in patients with Alzheimer's disease. Neurology. 47: 705-11. PMID 8797468 DOI: 10.1212/Wnl.47.3.705  0.414
1996 Stern Y, Liu X, Albert M, Brandt J, Jacobs DM, Del Castillo-Castaneda C, Marder K, Bell K, Sano M, Bylsma F, Lafleche G, Tsai WY. Application of a growth curve approach to modeling the progression of Alzheimer's disease. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. 51: M179-84. PMID 8681001 DOI: 10.1093/Gerona/51A.4.M179  0.397
1996 Devanand DP, Sano M, Tang MX, Taylor S, Gurland BJ, Wilder D, Stern Y, Mayeux R. Depressed mood and the incidence of Alzheimer's disease in the elderly living in the community. Archives of General Psychiatry. 53: 175-82. PMID 8629893 DOI: 10.1001/Archpsyc.1996.01830020093011  0.351
1995 Desmond DW, Tatemichi TK, Stern Y, Sano M. The determination of clinically meaningful cognitive decline: development and use of an alternative method. Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists. 10: 535-42. PMID 14588907 DOI: 10.1093/Arclin/10.6.535  0.396
1995 Stern Y, Albert M, Brandt J, Jacobs DM, Tang MX, Marder K, Bell K, Sano M, Devanand DP, Bylsma F. Utility of extrapyramidal signs and psychosis as predictors of cognitive and functional decline, nursing home admission, and death in Alzheimer's disease: prospective analyses from the Predictors Study. Neurology. 44: 2300-7. PMID 7991116 DOI: 10.1212/Wnl.44.12.2300  0.425
1995 Marder K, Richards M, Bello J, Bell K, Sano M, Miller L, Folstein M, Albert M, Stern Y. Clinical correlates of Alzheimer's disease with and without silent radiographic abnormalities. Archives of Neurology. 52: 146-51. PMID 7848122 DOI: 10.1001/Archneur.1995.00540260050015  0.381
1995 Jacobs DM, Sano M, Dooneief G, Marder K, Bell KL, Stern Y. Neuropsychological detection and characterization of preclinical Alzheimer's disease. Neurology. 45: 957-62. PMID 7746414 DOI: 10.1212/Wnl.45.5.957  0.422
1995 Jacobs DM, Marder K, Côté LJ, Sano M, Stern Y, Mayeux R. Neuropsychological characteristics of preclinical dementia in Parkinson's disease. Neurology. 45: 1691-6. PMID 7675228 DOI: 10.1212/Wnl.45.9.1691  0.396
1995 Sano M, Devanand DP, Richards M, Miller LW, Marder K, Bell K, Dooneief G, Bylsma FW, Lafleche G, Albert M. A standardized technique for establishing onset and duration of symptoms of Alzheimer's disease. Archives of Neurology. 52: 961-6. PMID 7575223 DOI: 10.1001/Archneur.1995.00540340045012  0.386
1995 Schafer K, Thal L, Bochenek J, Sano M, Grundman M, Woodbury P, Klauber M, Aisen P. P44 Implementation of multicenter clinical trials: The Alzheimer's Disease Cooperative Study protocol implementation manual Controlled Clinical Trials. 16: 97S. DOI: 10.1016/0197-2456(95)90524-9  0.369
1994 Tatemichi TK, Desmond DW, Stern Y, Paik M, Sano M, Bagiella E. Cognitive impairment after stroke: frequency, patterns, and relationship to functional abilities. Journal of Neurology, Neurosurgery, and Psychiatry. 57: 202-7. PMID 8126506 DOI: 10.1136/Jnnp.57.2.202  0.355
1994 Stern Y, Albert SM, Sano M, Richards M, Miller L, Folstein M, Albert M, Bylsma FW, Lafleche G. Assessing patient dependence in Alzheimer's disease. Journal of Gerontology. 49: M216-22. PMID 8056940 DOI: 10.1093/Geronj/49.5.M216  0.435
1994 Jacobs D, Sano M, Marder K, Bell K, Bylsma F, Lafleche G, Albert M, Brandt J, Stern Y. Age at onset of Alzheimer's disease: relation to pattern of cognitive dysfunction and rate of decline. Neurology. 44: 1215-20. PMID 8035918 DOI: 10.1212/Wnl.44.7.1215  0.431
1994 Tatemichi TK, Paik M, Bagiella E, Desmond DW, Stern Y, Sano M, Hauser WA, Mayeux R. Risk of dementia after stroke in a hospitalized cohort: results of a longitudinal study. Neurology. 44: 1885-91. PMID 7936242 DOI: 10.1212/Wnl.44.10.1885  0.317
1994 Lynch T, Sano M, Marder KS, Bell KL, Foster NL, Defendini RF, Sima AA, Keohane C, Nygaard TG, Fahn S. Clinical characteristics of a family with chromosome 17-linked disinhibition-dementia-parkinsonism-amyotrophy complex. Neurology. 44: 1878-84. PMID 7936241 DOI: 10.1212/Wnl.44.10.1878  0.328
1993 Stern Y, Folstein M, Albert M, Richards M, Miller L, Bylsma F, Lafleche G, Marder K, Bell K, Sano M. Multicenter study of predictors of disease course in Alzheimer disease (the "predictors study"). I. Study design, cohort description, and intersite comparisons. Alzheimer Disease and Associated Disorders. 7: 3-21. PMID 8481224 DOI: 10.1097/00002093-199307010-00002  0.397
1993 Richards M, Folstein M, Albert M, Miller L, Bylsma F, Lafleche G, Marder K, Bell K, Sano M, Devanand D. Multicenter study of predictors of disease course in Alzheimer disease (the "predictors study"). II. Neurological, psychiatric, and demographic influences on baseline measures of disease severity. Alzheimer Disease and Associated Disorders. 7: 22-32. PMID 8481223 DOI: 10.1097/00002093-199307010-00003  0.421
1993 Sano M, Bell K, Marder K, Stricks L, Stern Y, Mayeux R. Safety and efficacy of oral physostigmine in the treatment of Alzheimer disease. Clinical Neuropharmacology. 16: 61-9. PMID 8422658 DOI: 10.1097/00002826-199302000-00007  0.364
1993 Richards M, Bell K, Dooneief G, Marder K, Sano M, Mayeux R, Stern Y. Patterns of neuropsychological performance in Alzheimer's disease patients with and without extrapyramidal signs. Neurology. 43: 1708-11. PMID 8414017 DOI: 10.1212/Wnl.43.9.1708  0.436
1993 Stern Y, Richards M, Sano M, Mayeux R. Comparison of cognitive changes in patients with Alzheimer's and Parkinson's disease. Archives of Neurology. 50: 1040-5. PMID 8215961 DOI: 10.1001/Archneur.1993.00540100035011  0.436
1992 Tatemichi TK, Desmond DW, Mayeux R, Paik M, Stern Y, Sano M, Remien RH, Williams JB, Mohr JP, Hauser WA. Dementia after stroke: baseline frequency, risks, and clinical features in a hospitalized cohort. Neurology. 42: 1185-93. PMID 1603346 DOI: 10.1212/Wnl.42.6.1185  0.317
1992 Stern Y, Andrews H, Pittman J, Sano M, Tatemichi T, Lantigua R, Mayeux R. Diagnosis of dementia in a heterogeneous population. Development of a neuropsychological paradigm-based diagnosis of dementia and quantified correction for the effects of education. Archives of Neurology. 49: 453-60. PMID 1580806 DOI: 10.1001/Archneur.1992.00530290035009  0.326
1992 Sano M, Bell K, Cote L, Dooneief G, Lawton A, Legler L, Marder K, Naini A, Stern Y, Mayeux R. Double-blind parallel design pilot study of acetyl levocarnitine in patients with Alzheimer's disease. Archives of Neurology. 49: 1137-41. PMID 1444880 DOI: 10.1001/Archneur.1992.00530350051019  0.409
1991 Mayeux R, Sano M, Chen J, Tatemichi T, Stern Y. Risk of dementia in first-degree relatives of patients with Alzheimer's disease and related disorders. Archives of Neurology. 48: 269-73. PMID 2001183 DOI: 10.1001/Archneur.1991.00530150037014  0.417
1991 Chen JY, Stern Y, Sano M, Mayeux R. Cumulative risks of developing extrapyramidal signs, psychosis, or myoclonus in the course of Alzheimer's disease. Archives of Neurology. 48: 1141-3. PMID 1953398 DOI: 10.1001/Archneur.1991.00530230049020  0.378
1990 Sano M, Stern Y, Williams J, Coté L, Rosenstein R, Mayeux R. Coexisting dementia and depression in Parkinson's disease. Archives of Neurology. 46: 1284-6. PMID 2480103 DOI: 10.1001/Archneur.1989.00520480026014  0.335
1990 Sano M, Stern Y, Marder K, Mayeux R. A controlled trial of piracetam in intellectually impaired patients with Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 5: 230-4. PMID 2388639 DOI: 10.1002/Mds.870050308  0.399
1990 Stern Y, Hesdorffer D, Sano M, Mayeux R. Measurement and prediction of functional capacity in Alzheimer's disease. Neurology. 40: 8-14. PMID 2296387 DOI: 10.1212/Wnl.40.1.8  0.437
1989 Stern Y, Sano M, Mayeux R. Long-term administration of oral physostigmine in Alzheimer's disease. Neurology. 38: 1837-41. PMID 3057398 DOI: 10.1212/Wnl.38.12.1837  0.349
1988 Stern Y, Mayeux R, Sano M, Hauser WA, Bush T. Predictors of disease course in patients with probable Alzheimerʼs disease Alzheimer Disease & Associated Disorders. 2: 137. DOI: 10.1097/00002093-198802020-00017  0.319
1987 Stern Y, Sano M, Mayeux R. Effects of oral physostigmine in Alzheimer's disease. Annals of Neurology. 22: 306-10. PMID 3674795 DOI: 10.1002/Ana.410220305  0.324
1987 Stern Y, Mayeux R, Sano M, Hauser WA, Bush T. Predictors of disease course in patients with probable Alzheimer's disease. Neurology. 37: 1649-53. PMID 3658173 DOI: 10.1212/Wnl.37.10.1649  0.441
1987 Mayeux R, Stern Y, Sano M, Cote L, Williams JB. Clinical and biochemical correlates of bradyphrenia in Parkinson's disease. Neurology. 37: 1130-4. PMID 2439947 DOI: 10.1212/Wnl.37.7.1130  0.385
Show low-probability matches.